| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,032,576 ) |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 3 | NIH | 12/20/2022 | $362,571 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 000 | 2 | NIH | 1/12/2023 | $69,802 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 000 | 3 | NIH | 1/13/2023 | $37,979 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 2 | NIH | 1/26/2023 | $359,779 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 3 | NIH | 1/18/2023 | $40,286 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 000 | 1 | NIH | 10/21/2022 | $181,875 |
| | 2023 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E26HP17683 | PCL - Allopathic Medicine | 001 | 2 | HRSA | 11/28/2022 | $0 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21ES029566 | Neuronal P-Rex1 repression: a key factor in early-life environmental cigarette smoke exposure mediated risk of asthma | 000 | 2 | NIH | 11/24/2022 | $0 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01AG052627 | Mechanisms Controlling BubR1 Regulation of Cancer and Aging | 000 | 5 | NIH | 11/23/2022 | -$19,716 |
| | 2023 | 2018 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15GM129701 | Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function for the Development of Antibiological Agents | 001 | 1 | NIH | 12/9/2022 | $0 |
| | 2023 | 2018 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15GM129701 | Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function for the Development of Antibiological Agents | 000 | 1 | NIH | 11/1/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $12,116,724 ) (Continued on the next page) |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS118731 | Trans-synaptic signaling complex in amygdala pain mechanisms | 000 | 3 | NIH | 7/19/2022 | $530,374 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01NS107246 | Mechanisms of prion spread and establishment of infection | 000 | 5 | NIH | 5/3/2022 | $462,709 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016807 | Mechanisms of Biological Aging of Cochlear Hair Cells | 000 | 5 | NIH | 7/13/2022 | $376,598 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01DC016680 | Clinical factors in aminoglycoside-induced ototoxicity | 000 | 4 | NIH | 6/24/2022 | $666,714 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R21AI153688 | Role of RACK1 in RAG1 degradation and B cell development | 000 | 2 | NIH | 5/19/2022 | $181,875 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R15EY032275 | Novel ocular hypotensive and neuroprotective microparticle-based hydrogen sulfide delivery system | 000 | 1 | NIH | 2/9/2022 | $436,500 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 000 | 2 | NIH | 2/25/2022 | $1,924,360 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 001 | 2 | NIH | 7/6/2022 | $213,821 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 002 | 2 | NIH | 7/11/2022 | $0 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | T2946681 | Community Health Worker Training Program | 00 | 1 | HRSA | 9/7/2022 | $2,996,074 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 001 | 2 | NIH | 4/25/2022 | $717 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 002 | 2 | NIH | 5/23/2022 | -$1 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 000 | 2 | NIH | 1/24/2022 | $44,490 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 2 | NIH | 4/20/2022 | $41,449 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 2 | NIH | 12/22/2021 | $373,034 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 000 | 1 | NIH | 6/7/2022 | $508,224 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15AI156879 | Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs | 000 | 1 | NIH | 7/14/2022 | $436,468 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 000 | 1 | NIH | 5/19/2022 | $298,275 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 000 | 2 | NIH | 8/8/2022 | $249,000 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 1 | NIH | 3/29/2022 | $307,521 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 001 | 1 | NIH | 5/10/2022 | $51,854 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | D1832118 | Health Careers Opportunity Program | 00 | 5 | HRSA | 6/27/2022 | $622,466 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 3 | NIH | 5/4/2022 | $326,175 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R03AG070492 | Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia | 001 | 2 | NIH | 4/25/2022 | $14,550 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R03AG070492 | Characterizing upstream regulators of glucosylceramide metabolism for Parkinson's disease and Lewy Body Dementia | 000 | 2 | NIH | 12/10/2021 | $130,950 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R21AI159127 | A novel form of light chain gene replacement | 000 | 2 | NIH | 12/3/2021 | $181,875 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01MH116003 | Function of glutamate delta-1 receptor | 000 | 5 | NIH | 6/15/2022 | $376,429 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01NS103763 | Mechanisms of prion strain dynamics | 000 | 5 | NIH | 6/8/2022 | $370,563 |
| | 2022 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 000 | 3 | NIH | 6/22/2022 | $0 |
| | 2022 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E0118936 | Nurse Faculty Loan Program | 02 | 3 | HRSA | 8/15/2022 | $0 |
| | 2022 | 2021 | Creighton University | 2500 California Plaza | Omaha | NE | 68178-0002 | DOUGLAS | USA | E0118936 | Nurse Faculty Loan Program | 01 | 3 | HRSA | 1/10/2022 | $0 |
| | 2022 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 001 | 3 | NIH | 9/1/2022 | $0 |
| | 2022 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC004555 | Hair Cell Responses to Ototoxic Drugs | 000 | 17 | NIH | 5/12/2022 | -$495 |
| | 2022 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI116323 | Molecular basis of intestinal cryptosporidiosis | 001 | 6 | NIH | 10/22/2021 | -$292,989 |
| | 2022 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI116323 | Molecular basis of intestinal cryptosporidiosis | 000 | 6 | NIH | 10/22/2021 | $292,989 |
| | 2022 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC015010 | Genetic control of cellular conversion in the mature cochlea | 000 | 5 | NIH | 7/14/2022 | $0 |
| | 2022 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01AG052627 | Mechanisms Controlling BubR1 Regulation of Cancer and Aging | 000 | 5 | NIH | 3/18/2022 | -$109 |
|
